Medical Congress News

Medical Digest & Congress Report

Health EN ↓ 724 episodes

The MedicalDigest.org / CongressReport.eu podcast covers the latest evidence based medical news from cardiology, hematology, oncology, diabetology, pulmonology, dermatology, urology and more. Made for healthcare professionals and researchers, we are an independent, open-access platform. CongressReport.eu portal enables HCPs to get acquainted with new clinical trial results, medical diagnostic and treatment guidelines. Our non-promotional website collects and stores the relevant scientific information, KOL insights, key lectures, poster presentations in a user-friendly format.

Author

Medical Congress News

Episodes

Lymphoma and CLL highlights of the ASH 2025 09.01.2026 6:17

Catherine S. Diefenbach discusses the lymphoma and CLL highlights at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:lymphoma-and-cll-highlights-ash-2025

Quadruplet Therapy in Multiple Myeloma - report from ASH 2025 07.01.2026 12:00

Rahul Banerjee discusses the quadruplet therapy in multiple myeloma at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:quadruplet-therapy-multiple-myeloma

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL - report from ASH 2025 07.01.2026 6:26

Jennifer Woyach discusses the noncovalent BTK inhibitor pirtobrutinib achieved noninferiority to the covalent BTK inhibitor ibrutinib in terms of overall response rate in patients with CLL or SLL, according to findings from a randomized phase III trial presented at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:non-coval...

Primary efficacy analysis of TKI and inotuzumab ozogamicin-based therapy for newly diagnosed Ph+ ALL - report from ASH 2025 07.01.2026 4:38

Anand A. Patel discusses the primary efficacy analysis of a Phase II study investigating tyrosine kinase inhibitor and inotuzumab ozogamicin-based therapy for newly diagnosed Philadelphia-chromosome-positive acute lymphoblastic leukemia at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:primary-efficacy-analysis-tki-and-i...

Validation of measurable residual disease as a surrogate endpoint in acute myeloid leukemia: A HARMONY Alliance study of European randomized trials - report from ASH 2025 07.01.2026 6:06

Jesse Tettero discusses the results from the HARMONY Alliance study at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:validation-measurable-residual-disease-surrogate-endpoint-acute-myeloid-leukemia-harmony-alliance-study-european-randomized-trials

Symptom-based progression-free survival as a clinically relevant and patient-centric endpoint in chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the ALPINE trial 07.01.2026 2:55

Jennifer R. Brown explains the results from the ALPINE trial at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:symptom-based-progression-free-survival-clinically-relevant-and-patient-centric-endpoint-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma-results-alpine-trial

Azacitidine–Venetoclax Combination Outperforms Standard Care in Acute Myeloid Leukemia Patients Eligible for Intensive Chemotherapy - report from ASH 2025 07.01.2026 6:18

Amir Fathi discusses the results from a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:azacitidinevenetoclax-combination-outperforms-standard-care...

What's new in myeloma? - report from ASH 2025 07.01.2026 3:09

Enrique Ocio discusses what's new in multiple myeloma treatement at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:whats-new-myeloma

Novelties in Acute Myeloid Leukemia at ASH2025 07.01.2026 4:28

Mark Levis discusses the novelties in acute myeloid leukemia at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:novelties-acute-myeloid-leukemia-ash2025

State of the art treatment of Chronic Myeloid Leukemia - report from ASH 2025 18.12.2025 5:43

Michael J. Mauro discusses the state of the art treatment of chronic myeloid leukemia at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-chronic-myeloid-leukemia

Myelodysplastic Syndrome Highlights from ASH 2025 18.12.2025 5:15

Mikkael A. Sekeres discusses the state of the art treatment in myelodysplastic syndrome at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:myelodysplastic-syndrome-highlights-ash-2025

COBRA trial and other novelties in multiple myeloma at ASH 2025 18.12.2025 16:04

Andrzej Jakubowiak discusses the COBRA trial and other novelties in multiple myeloma at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:cobra-trial-and-other-novelties-multiple-myeloma-ash-2025

Multiple Myeloma Highlights from ASH 2025 18.12.2025 9:10

Paul G Richardson discusses multiple myeloma highlights at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:multiple-myeloma-highlights-ash-2025

Diagnosis and Management of Cold Agglutinin Disease - report from ASH 2025 18.12.2025 13:20

Sigbjorn Berentsen discusses the diagnosis and management of cold agglutinin disease at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:diagnosis-and-management-cold-agglutinin-disease

Breakthrough in the treatement of Multiple Myeloma - report from ASH 2025 18.12.2025 11:20

Xavier Leleu explains the breakthrough in the treatement of multiple myeloma at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:breakthrough-treatement-multiple-myeloma

Novelties in Diffuse Large B-cell Lymphoma at ASH2025 18.12.2025 6:08

Joshua Brody discusses the novelties in diffuse large B-cell lymphoma at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:novelties-diffuse-large-b-cell-lymphoma-ash2025

First-of-Its-Kind Phase 3 Trial Shows Pirtobrutinib Is Noninferior to Ibrutinib in Treatment-Naïve CLL - report from ASH 2025 17.12.2025 6:53

Wojciech Jurczak discusses the results from the global, randomized BRUIN CLL-313 study presented at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:first-its-kind-phase-3-trial-shows-pirtobrutinib-noninferior-ibrutinib-treatment-naive-cll

New findings support a chemo-free approach for treating Ph+ ALL - report from ASH 2025 17.12.2025 8:37

Sabina Chiaretti discusses the results of the phase 3 GIMEMA ALL2820 study at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:new-findings-support-chemo-free-approach-treating-ph-all

Novel Agent Ianalumab Added to Standard Therapy Extends Time to Treatment Failure in Patients with Previously Treated Immune Thrombocytopenia - report from ASH 2025 17.12.2025 6:07

Hanny Al-Samkari discusses the results from VAYHIT2, a randomized, double-blind, phase 3 trial of ianalumab plus eltrombopag versus placebo plus eltrombopag in patients with primary immune thrombocytopenia who failed first-line corticosteroid treatment at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:novel-agent-ianalum...

Bispecific Combo May Offer “Functional Cure” in Multiple Myeloma - report from ASH 2025 17.12.2025 8:52

María-Victoria Mateos discusses the results of a phase 3 study of teclistamab plus daratumumab for relapsed refractory multiple myeloma presented at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:bispecific-combo-may-offer-functional-cure-multiple-myeloma

Epcoritamab Combo Significantly Improves Efficacy in 2L R/R Follicular Lymphoma - report from ASH 2025 17.12.2025 5:02

Lorenzo Falchi discusses the results of phase 3 EPCORE FL-1 trial presented at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:epcoritamab-combo-significantly-improves-efficacy-2l-rr-follicular-lymphoma

Novelties in Follicular Lymphoma at ASH2025 17.12.2025 6:35

Joshua Brody discusses the novelties in follicular lymphoma at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:novelties-follicular-lymphoma-ash2025

Remote BP Monitoring and Drug Titration – Does it work? How do we do it? - report from AHA 2025 03.12.2025 13:03

Professor Beverly B. Green shares her insights on remote BP monitoring and drug titrationat after the AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:remote-bp-monitoring-and-drug-titration-does-it-work-how-do-we-do-it

Effectiveness of High-Dose vs. Standard-Dose Inactivated Influenza Vaccine in Individuals with and without Atherosclerotic Cardiovascular Disease: A Pooled FLUNITY-HD Trial Analysis 03.12.2025 9:30

Professor Manan Pareek shares his insights on the results from the FLUNITY-HD trial analysis at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:effectiveness-high-dose-vs-standard-dose-inactivated-influenza-vaccine-individuals-and-without-atherosclerotic-cardiovascular-disease-pooled-flunity-hd-trial-analysis

Blood Pressure and Symptomatic Hypotension with Dapagliflozin vs. Placebo in Patients Hospitalized with Heart Failure - report from AHA 2025 03.12.2025 3:02

Professor Siddharth M. Patel shares his insights on the results from the DAPA ACT HF-TIMI 68 trial at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:blood-pressure-and-symptomatic-hypotension-dapagliflozin-vs-placebo-patients-hospitalized-heart-failure